Gossamer Bio (GOSS) Consolidated Net Income: 2022-2025
Historic Consolidated Net Income for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$48.2 million.
- Gossamer Bio's Consolidated Net Income fell 56.55% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.2 million, marking a year-over-year increase of 5.12%. This contributed to the annual value of -$56.5 million for FY2024, which is 68.56% up from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's Consolidated Net Income is -$48.2 million, which was down 31.61% from -$36.6 million recorded in Q2 2025.
- Gossamer Bio's Consolidated Net Income's 5-year high stood at -$30.8 million during Q3 2024, with a 5-year trough of -$59.0 million in Q3 2022.
- Its 3-year average for Consolidated Net Income is -$42.1 million, with a median of -$41.9 million in 2024.
- Per our database at Business Quant, Gossamer Bio's Consolidated Net Income skyrocketed by 32.23% in 2023 and then tumbled by 56.55% in 2025.
- Quarterly analysis of 4 years shows Gossamer Bio's Consolidated Net Income stood at -$57.2 million in 2022, then climbed by 15.85% to -$48.1 million in 2023, then skyrocketed by 31.40% to -$33.0 million in 2024, then crashed by 56.55% to -$48.2 million in 2025.
- Its last three reported values are -$48.2 million in Q3 2025, -$36.6 million for Q2 2025, and -$39.3 million during Q1 2025.